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Mansonic schistosomiasis is a para-
sitic disease that affects more than 15
million individuals in Brazil.
Hepatosplenic schistosomiasis (HS) is
the most severe presentation of the
disease, which is characterized by ex-
tensive splenomegaly, periportal fibro-
sis, portal hypertension, and upper di-
gestive bleeding due to rupture of
esophageal varices1.
Development of portal hypertension
(PH), regardless of its etiology, is due to
increased vascular resistance or in-
creased portal venous flow or both2-5. In
cirrhosis and schistosomiasis, although
increased vascular resistance appears to
be the initial event, mesenteric
hyperflow is important in maintaining
portal hypertension1,3-6. The pathophysi-
ology of PH also frequently displays a
systemic hyperdynamic state7-10 due to
portal shunting of splanchnic vasoactive
mediators11,13-16.
Nevertheless, findings regarding
portal hemodynamics in hepatosplenic
mansonic schistosomiasis remain con-
troversial. Total hepatic blood flow
was reportedly preserved in previous
studies17,18,19,20. It should be empha-
sized that none of those studies em-
ployed direct measurements18,21-24. An-
other important characteristic of
schistosomal portal hypertension is
extensive splenomegaly with dilated
spleen vessels, suggesting that the
splanchnic hyperflow is largely due to
splenic hyperflux22,23,25.
The purpose of this study was to
assess portal hemodynamics with the
thermodilution technique in patients
with PH due to HS as well as to assess
the contribution of splenic flow to the
pathophysiology of the portal hyper-
tension.
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PURPOSE: The purpose of this study was to assess portal hemodynamics in patients with portal hypertension due to
hepatosplenic schistosomiasis as well as to assess the contribution of splanchnic hyperflow to the pathophysiology of the
portal hypertension.
METHODS: Sixteen patients with schistosomal portal hypertension and previous history of upper digestive bleeding
due to esophageal varices rupture underwent elective esophagogastric devascularization and splenectomy and were
prospectively studied. All patients underwent intraoperative invasive hemodynamic portal monitoring with a 4F-
thermodilution catheter. The intraoperative portal hemodynamic assessment was conducted after laparotomy (initial) and
after esophagogastric devascularization (final).
RESULTS: The initial portal pressure was elevated (mean 28.5 ± 4.5 mm Hg), and a significant drop of 25% was
observed at the end of the surgery (21.9 ± 4.9 mm Hg). The initial portal flow was elevated (mean 1766.9 ± 686.6 mL/min).
A significant fall (42%) occurred at the end of the surgical procedure (1025.62 ± 338.7 mL/min). Fourteen patients (87.5%)
presented a portal flow of more than 1200 mL/min, and in 5 cases, values greater than 2000 mL/min were observed.
CONCLUSIONS: Esophagogastric devascularization and splenectomy promote a significant reduction of the elevated
portal pressure and flow in schistosomal portal hypertension. These data favor the hypothesis of portal hyperflow in the
physiopathology of portal hypertension of schistosomiasis.
DESCRIPTORS: Hemodynamics. Portal hypertension. Portal system. Mansonic schistosomiasis.
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METHODS  AND  PATIENTS
From June 1992 to July 1996, 16
patients with schistosomal portal hy-
pertension (PH) and a previous history
of upper digestive bleeding due to
rupture of esophageal varices under-
went elective esophagogastric devas-
cularization and splenectomy and
were prospectively studied.
The patients were hospitalized with
the Liver and Portal Hypertension
Group of the Division of the Digestive
Tract Surgery of our Hospital. The Eth-
ics Committee of the Hospital ap-
proved the study protocol, and all pa-
tients signed an informed consent.
The study included only patients
with PH resulting from Manson’s HS
with esophageal varices and a history
of upper digestive bleeding
(hematemesis or melena) for more than
30 days. Patients included 8 males and
8 females, their ages ranging from 15
to 70 years (mean 39 ± 13). The diag-
nosis was based on epidemiological
data (living in endemic regions of
schistosomiasis in Brazil), history (pre-
vious contact with water contaminated
by S. mansoni), physical examination
(hepatomegaly with prominence of the
left lobe, extensive splenomegaly, and
collateral abdominal circulation), and
laboratory evaluation (normal hepato-
cellular function). Upper digestive en-
doscopy was performed for detection
of esophagogastric varices. The diag-
nosis was confirmed by identification
of S. mansoni eggs on parasitological
stool examination. Only those patients
whose disease was confirmed
(Symmer’s fibrosis and granulomata
with S. mansoni eggs) by histological
study of the intraoperative hepatic bi-
opsy were included in this series. The
exclusion criteria were thrombosis of
the portal, splenic, or superior me-
senteric veins assessed by ultrasonog-
raphy or arteriography; chronic viral
hepatitis (B and C), with evidence of
hepatocellular lesions confirmed by
intraoperative biopsy; any type of
heart disease; chronic alcoholism; and
patients in endoscopic sclerotherapy
programs.
All patients underwent elective
esophagogastric devascularization and
splenectomy. The procedure consisted
of ligature of the splenic artery close
to the body of the pancreas followed
by splenectomy and devascularization
of the distal esophagus (5 to 7 cm) and
of the upper two-thirds of the stomach
(proximal to the incisura angularis).
During surgery, portal pressure (PP)
and flow (PF) were measured using a
4F thermodilution catheter (94-010H-
4F, Baxter Corporation, EUA) inserted
from a jejunal vein through the infe-
rior mesenteric vein, locating the ther-
mistor close to the tip of the catheter
beyond the portal bifurcation and the
injection hole in the middle of the por-
tal vein (Fig.1), similar to the tech-
nique employed for measurement of
cardiac output with the pulmonary ar-
tery catheter. When the pulmonary ar-
tery catheter is properly placed, the in-
jection hole is located at the right
atrium, and the thermistor is located at
the right pulmonary artery.
The PP was electronically meas-
ured using a Hewlett Packard model
1290 C pressure transducer, while PF
was measured in triplicate using the
thermodilution technique via the
Hewlett Packard (model 783390A)
Cardiac Output (CO) computer after
the injection of 5 mL of 5% glucose
at 0 to 4 oC. Portal pressure and PF
were assessed after laparotomy (initial)
as well as after esophagogastric devas-
cularization and splenectomy (final).
In this study, a PP between 5 and 10
mm Hg and a PF between 800 and 1200
mL/min were considered normal26. Sta-
tistical analysis was accomplished us-
ing a paired t test, and p values <0.01
were considered statistically significant.
RESULTS
The individual results are reported
on table 1.
The initial PP was elevated (mean
28.5 ± 4.5 mm Hg), and a significant
drop of 25% was observed at the end
of the surgery (21.9 ± 49 mm Hg). The
initial PF was elevated (mean 1766.9
± 686.6 mL/min). A significant fall
Figure 1 - Illustration showing the correct positioning of the 4F thermodilution catheter inside
the portal vein.
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(42%) occurred at the end of the sur-
gical procedure (1025.62 ± 338.7mL/
min). ). Fourteen patients (87.5%) pre-
sented a PF greater than 1200 mL/min,
and in 5 cases, values greater than
2000 mL/min were observed.
DISCUSSION
Portal hypertension is a syndrome
characterized by increased vascular re-
sistance and/or increased portal ve-
nous flow5,26. Characteristically,
portosystemic collateral circulation
and digestive hemorrhage through
esophageal varices occur independ-
ently from hepatocellular function.
The study of portal hemodynamics
is very important for the understand-
ing of the pathophysiology of portal
hypertension in hepatosplenic
mansonic schistosomiasis and for the
determination of the physiological ef-
fects following surgical treatment.
Since there is no consensus about the
ideal surgical procedure for treatment
of schistosomal portal hypertension,
portal and systemic hemodynamic pro-
files could help to determine the best
surgical technique for these patients—
either esophagogastric devasculariza-
tion and splenectomy or splenorenal
distal shunt27-31.
There are no other studies that have
assessed intraoperative PF by thermodi-
lution in schistosomiasis. In our series,
both the initial PF (1767 ± 692 mL/
min) and PP (28.5 ± 4.5 mm Hg) were
elevated. These findings are in agree-
ment with the theory that portal
hyperflow plays a major role in the ori-
gin and maintenance of schistosomal
portal hypertension32-33.
Nine patients (56.25%) presented
portal flow values greater than what is
considered normal for total hepatic flow
(1500 mL/min). These results are in disa-
greement with previous findings of other
authors who report portal hyperflow with
preserved total hepatic blood flow22-25.
The 40% portal flow decrease at
the end of the surgery (from 1767 to
1025 mL/min) suggests a greatly in-
creased contribution of splenic flow to
the total portal flow. Interestingly, our
group had previously demonstrated
that mansonic schistosomiasis presents
a hyperdynamic systemic circulatory
state that is also corrected by
esophagogastric devascularization and
splenectomy, demonstrating the impor-
tance of the spleen and collateral cir-
culation in these circulatory states34.
In conclusion, these data favor the
hypothesis of portal hyperflow in the
physiopathology of portal hyperten-
sion of schistosomiasis.
Table 1 - Individual and mean results of portal pressure and portal flow before and
after esophagogastric devascularization and splenectomy.
Case SEX PPi PPf FPi FPf
01 F 29 17 2640 810
02 F 24 12 1500 980
03 F 26 23 1310 1000
04 M 30 20 3210 920
05 M 26 20 2336 1050
06 F 29 17 2590 1250
07 F 28 23 1930 1610
08 M 29 25 1270 1500
09 M 28 22 690 580
10 F 30 19 2240 1310
11 M 30 22 1090 1130
12 M 43 38 1850 500
13 F 30 23 1140 720
14 M 22 17 1380 540
15 F 27 25 1860 1400
16 M 26 26 1240 1110
Mean + SD 28.6 + 4.50 21.8 + 5.7* 1767 + 686* 1026 + 339*
p < 0.0001
Ppi: Initial portal pressure; PPf: Final portal pressure; Fpi: Initial portal flow; FPf: Final portal flow
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OBJETIVOS: o objetivo do pre-
sente estudo é estudar a hemodinâmica
portal em pacientes com hipertensão
portal secundária a forma hepatoes-
plênica da esquistossomose e avaliar
a contribuição do hiperfluxo esplênico
na sua fisiopatologia
CASUÍSTICA E MÉTODOS: Fo-
ram estudados prospectivamente 16 pa-
cientes portadores de hipertensão por-
tal secundária à forma hepatoesplênica
da esquistossomose mansônica com in-
dicação de tratamento cirúrgico. Todos
foram submetidos a avaliação hemo-
dinâmica portal com cateter de termo-
diluição 4F antes e após a realização de
desvascularização esofago-gástrica com
esplenectomia.
RESULTADOS: Na avaliação
intra-operatória inicial observou-se
pressão (28,5 + 4,5 mmHg ) e fluxo
(1750,59 + 668,14 ml/min) portais ini-
ciais bem acima dos valores conside-
rados normais. Houve queda signi-
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ficante de 25% na pressão (21,65 +
5,55 mmHg ) e de 42% no fluxo
(1011,18 + 332,73 ml/min) ao térmi-
no da cirurgia. Quatorze pacientes
(87.5%) apresentavam fluxo portal
superior a 1200 ml/min e, em 5 casos,
valores superiores a 2000 ml/min fo-
ram observados.
CONCLUSÕES: A pressão e o flu-
xo portais estão aumentados na hiper-
tensão portal esquistossomótica. A
desvascularização esofago-gástrica
com esplenectomia reduz significati-
vamente tanto a pressão quanto o flu-
xo portais. Estes dados favorecem a hi-
pótese do hiperfluxo esplâncnico
(esplênico e mesentérico) na fisiopa-
tologia da hipertensão portal na es-
quistossomose forma hepatoesplênica.
DESCRITORES: Hipertensão por-
tal. Hemodinâmica. Sistema porta.
Esquistossomose mansônica.
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